CMAAO: In susceptible high-risk (pro-inflammatory and/or pro-coagulative) individuals, reactogenic vaccines can trigger transient thrombo-inflammation lasting first few (up to four) days. COVID Vaccine: non-replicative, non-repetitive …Read more
CMAAO: In susceptible high-risk (pro-inflammatory and/or pro-coagulative) individuals, reactogenic vaccines can trigger transient thrombo-inflammation lasting first few (up to four) days. COVID Vaccine: non-replicative, non-repetitive …Read more
New research published in The Lancet Respiratory Medicine has found that seropositive healthy young adults are still at risk of reinfection. A prospective cohort study was …Read more
CMAAO: In susceptible high-risk (pro-inflammatory and/or pro-coagulative) individuals, reactogenic vaccines can trigger transient thrombo-inflammation lasting first few (up to four) days. COVID Vaccine: non-replicative, non-repetitive …Read more
Copyright © 2022 | All Rights Reserved. | Powered by Dr K K Aggarwal